Skip to main content
Lincoln Pharmaceuticals ltd. logo

Lincoln Pharmaceuticals ltd. — Investor Relations & Filings

Ticker · LINCOLN ISIN · INE405C01035 LEI · 3358004B6OBJNW8RTT10 BSE.NS Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2020-10-09 Regulatory Filings
Country IN India
Listing BSE.NS LINCOLN

About Lincoln Pharmaceuticals ltd.

https://www.lincolnpharma.com/

Lincoln Pharmaceuticals Ltd. focuses on the development, manufacturing, and marketing of a diverse range of therapeutic formulations. The organization operates advanced manufacturing facilities certified by international standards, including WHO-GMP. Its portfolio spans multiple areas such as anti-infectives, cardiovascular, gastrointestinal, respiratory, and pain management. The company is recognized for its research and development initiatives, particularly in Novel Drug Delivery Systems (NDDS). Key offerings include specialized treatments for tinnitus and a wide array of formulations in dosage forms like tablets, capsules, liquid orals, and injectables. It maintains a significant global footprint, supplying products to numerous international markets across Africa, Southeast Asia, and Latin America, supported by a robust distribution network for its extensive healthcare catalog.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 90% confidence The document is very short (728 characters) and consists mainly of addresses to stock exchanges (National Stock Exchange of India Limited and BSE Limited) and scrip codes. There is no substantive financial data, report content, or detailed information. The presence of stock exchange addresses and scrip codes suggests this is likely a regulatory announcement or filing rather than a full report. Given the brevity and lack of detailed content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2020-10-09 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed submission of voting results from the 26th Annual General Meeting (AGM) of Lincoln Pharmaceuticals Limited, including the scrutinizer's report and voting statistics for resolutions passed. It references Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of voting results. The content focuses on the official announcement of voting outcomes and related procedural details rather than the AGM materials or the full annual report. The document is not a transcript, financial report, or management discussion but specifically the official voting results announcement following the AGM. Therefore, the appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support a high confidence level.
2020-10-01 English
Shareholders meeting
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and no textual content or financial data. It is extremely short (599 characters) and does not contain any report, announcement, or detailed information. Given the lack of substantive content, it does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2020-09-30 English
Trading Window
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no textual content or substantive information. It is extremely short (219 characters) and does not contain any financial data, report titles, regulatory references, or announcements. Given the lack of content, it cannot be classified as a report or announcement. The best fit is the fallback category Regulatory Filings (RNS) due to absence of any other identifiable filing type.
2020-09-30 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice and newspaper advertisement related to a court/NCLT (National Company Law Tribunal) convened meeting concerning a scheme of amalgamation between Lincoln Parenteral Limited and Lincoln Pharmaceuticals Limited. It includes details about the meeting date, mode (video conferencing), and the involved parties. There is no financial data, earnings, or management discussion. The document is an official announcement about a meeting related to a merger/amalgamation scheme, not the merger filing itself or a financial report. This fits best under Regulatory Filings (RNS) as it is a formal regulatory announcement about a court-ordered meeting for shareholders and creditors regarding the amalgamation scheme.
2020-09-29 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple notices related to Annual General Meetings (AGMs) of various companies, including details about the date, venue (video conferencing), book closure, and e-voting information. It also includes newspaper advertisements and official communications about the AGM notices. There is no detailed financial data or comprehensive financial statements present. The document primarily serves as an announcement and information dissemination about the AGM and related voting procedures. Therefore, it fits the category of AGM Information (AGM-R) rather than the full Annual Report or other financial filings.
2020-09-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.